Epstein Secrets

09/18/2018 16:38 From: INIMINIM Woodson C. Merrell M Uebfax Page: 1/11 FAX COVER SHEET To: Jeffrey Epstein / Lesley From: Lisa Company: Company: Woodson Merrell MD PLLC Phone: Pages w/cover: 11 Fax: Date: 9/18/2018 Subject: 9-14-18 LABCORP (

/2010 16:30 From: 3477565616 Woodson C. Merrell M Wehfax Page: 2/11 LabCorp Patient Report Specimen ID: 257-480 2371-0 Control ID: FSB31: 43092 EPSTEIN, JEFFREY 9E 71STST NEW YORK W 10021 Acct 31143092 Woodson Merrell 44 E67th St New York NY 10065 Phone Patient Details Specimen Details Phy

30 From: 3477565616 Woodson C. Merrell M Wehfax Page: 2/11 LabCorp Patient Report Specimen ID: 257-480 2371-0 Control ID: FSB31: 43092 EPSTEIN, JEFFREY 9E 71STST NEW YORK W 10021 Acct 31143092 Woodson Merrell 44 E67th St New York NY 10065 Phone Patient Details Specimen Details Physician De

.8 g/dL 31.5 - 35.7 01 RDW 14.6 t 12.3 - 15.4 01 Platelets 242 x1083/uL 150 - 379 01 Neutrophils 50 I Not Estab. 01 Lymphs 37 % Not Estab. 01 Monocytes 5 * Not Estab. 01 Eos 7 * Not Estab. 01 Basos 1 * Not Estab. 01 Neutrophils (Absolute) 2.8 x10E3/uL 1.4 - 7.0 01

09/21/2018 10:18 From: Woodson C. Merrel l M Uebfax Page: 1/13 FAX COVER SHEET fo: Jeffrey Epstein / Company: Fax: Date: 9/21/2018 Subject: 9-14-18 LABCORP Lab Results Jeff From: Lisa Company: Woodson Merrell MD PLLC Phone: Pages w/cove

99800 09/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ",r-lbrU-2371-0 Convo! ID: F3 [143092 EPSTEIN, JEFFREY IS: ST NEW YORK NY 10021 Acct 31143092 Woodson Merrell 44E6AhS( New York NY 10065 Phone: Patient Details Specimen Details Physici

9/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ",r-lbrU-2371-0 Convo! ID: F3 [143092 EPSTEIN, JEFFREY IS: ST NEW YORK NY 10021 Acct 31143092 Woodson Merrell 44E6AhS( New York NY 10065 Phone: Patient Details Specimen Details Physician Detail

51.0 01 86 IL 79 - 97 01 30.0 pg 26.6 - 33.0 01 34.8 g/dL 31.5 - 35.7 01 14.6 t 12.3 - 15.4 01 242 xl0E3/u1 150 - 379 01 50 * Not Estab. 01 37 * Not Estab. 01 5 t Not Estab. 01 7 t Not Estab. 01 1 t Not Estab. 01 2.8 x10E3/uL 1.4 - 7.0 01 Lymphs (Absolute) 2.1

y ki-vvn ineyb vs>f EFTA00282983 BioReference LABORATORIES FINAL REPORT 0 0 L riscw, HARRY HARRY FISCH. M.D. New York, MY 10028 51 P: EPSTEIN, ]ErrRre D08:01/2%/1953 Age:63 Y Sex:PI ,Address: E 71ST STREET -.NEW YORK ( NY 5 A M Specimen ID: 105819158 Date Of Report:07/23/2016 Dat

RRY HARRY FISCH. M.D. New York, NY 10028 Acct ft: C1720-1) S1 P: i olL. EPSTEIN, 0000:01/20/1953 Address:3 NEW YORK P: a) i.V • tar JEFFREY Age:63 Y Sex:M I /1ST S-REET Niiiiiiii 5 Specimen ID: 105819158 A Date Of Report: 07/23/2616 M Date Collected:07/20/2616 P Time Collected:

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

09,18,2016 16:30 Froe: lioodson C. Merrell M Webfax Page: 2,11 3LabCorp Patient Report Specimen iD: 21, 7 -0 Control ID:r5 : 43)92 EPSTEIN, JEFFREY 9 E 7ISTST NEW YORK NY 10:;' Patient Details 008:01/20/1953 Age(y/m/d): 065437/25 Ginder: M 55ft Patient IM Acct F.31143092 Phon.:

09,18,2016 16:30 Froe: lioodson C. Merrell M Webfax Page: 2,11 3LabCorp Patient Report Specimen iD: 21, 7 -0 Control ID:r5 : 43)92 EPSTEIN, JEFFREY 9 E 7ISTST NEW YORK NY 10:;' Patient Details 008:01/20/1953 Age(y/m/d): 065437/25 Ginder: M 55ft Patient IM Acct F.31143092 Phon.: Rte: 68

7 g/dL 13.0 17.7 42.2 37.5 51.0 86 fL 79 97 30.0 pg 26.6 33.0 34.8 g/dL 31.5 35.7 14.6 12.3 15.4 242 x10133/uL 150 - 379 50 Not Estab. 37 Not Estab. 5 Not Estab. 7 Not Estab. 1 Not Estab. 2.8 x1083/uL 1.4 - 7.0 2.1 x1023/uL 0.7 - 3.1 0.3 x1083/ul. 0.1 - 0.9 0.4 x1

1,2918 18:18 From: Uoodson C. Merrell M Uebfax Page: 2/13 eLabcorp Specimen ID: 151-480-2371-0 Control m F5831143092 Patient Report EPSTEIN,JEFFRET 9 E 71ST ST NEW YORK NY 10021 Patientnails P08:01/20/1953 Aselykerd):063107/2.5 Gender: M SSN: Patient XX Acct 31143092 Phone ate: 68 Wo

89,21,2918 18:18 From: Uoodson C. Merrell M Uebfax Page: 2/13 eLabcorp Specimen ID: 151-480-2371-0 Control m F5831143092 Patient Report EPSTEIN,JEFFRET 9 E 71ST ST NEW YORK NY 10021 Patientnails P08:01/20/1953 Aselykerd):063107/2.5 Gender: M SSN: Patient XX Acct 31143092 Phone ate

MCHC 34.8 g/dL 31.5 - 35.7 01 RDW 14 .6 12.3 - 15.4 01 Platelets 242 x10E3/uL 150 - 379 01 Neutrophils 50 Not &stab. 01 Lymphs 37 Not Estab. 01 Monocytes 5 Not Estab. 01 EOS 7 Not Estab. 01 8a808 1 Not Estab. 01 Neutrophils (Absolute) 2.8 x10E3/uL 1.4 - 7.0 01 Lymphe (A

oReference PRELIMINARY LABORATORIES D 0 T C R FISCH, HARRY C1720 - HARRY FISCH, M.D. NEW YORK, NY 10028 Acct #: (C1720) P: S1 L EPSTEIN, JEFFREY P DOB: 01/20/1953 Age: 63 y Sex: M A U/FL: Bed: T Rm: I Patient ID: E Address:9 EAST 71ST STREET, N NEW YORK, NY 10021 P: (212)772-9416 (No

30 EFTA00599643 BioReference D LABORATORIES T C R FISCH, HARRY C1720 - HARRY FISCH, M.D. NEW YORK, NY 10028 Acct #: C1720 P: S1 I I T EPSTEIN, JEFFREY P DOB: 01/20/1953 Age: 63 y Sex: M A U/FL: Bed: T Rm: I Patient ID: E Address:9 EAST 71ST STREET, N NEW YORK, NY 10021 P: (212)772-

the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE 0.33 Not Estab. ng/mL I 0.31 10/27/201S BioReference Laboratories, Inc. Elmwood Park, NJ 07407 James Weisberger M.D. Page 3 of S Laboratory Director Prin

nce LABORATORIES FINAL REPORT 0, FISCH, HARRY \ 0 HARRY FISCH, M.D. ( 944 PARK AVENUE New York, NY 10028 Acct P: (C1720-1) Si C P: R EPSTEIN, D08:01/20/1953 Address:9 s 'OM YORK IP: gliNS JEFFREY Specimen ID: 105819158 Age:63 Y Sex:Pt Date Of Report: 07/23/2016 E 71ST STREET Dat

ARRY A HARRY FISCH, H.D. L 944 PARK AVENUE York, NY 10028 T Acct a: C1720-1) S1 R EPSTEIN, D00:01/20:1953 Address:, NEW YORK P: (212) JEFFREY Age:63 Y Sex:m E 71ST STREET NY 10021 772-9c16 , ,s STRAKFTC4.4,0* iifkiiSii (>or=70 yrs) 64.5% 40.8% 29.7% 15.8% biopsy ible when the va

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

(212) , LABORATORIES n FISCH, HARRY 0 HARRY FISCH, M.D. 944 PARK AVENUE New York, NY 10028 Acct I: (C1720-1) Si 0 P: (212) 879-0800 P, JEFFREY Age:63 Y Sex:/1 E 71ST STREET NY 10021 772-9415 S Specimen ID: 105819158 A Date Of Report: 07/23/2016 M Date Collected: 07/20/2016 Time Col

£91926ZI.a. L-Pstd kueH WdL£SO 9I.62 60 5rY EFTA01733942 9490L000 L2!—V.Ld3 FINAL REPORT J-11,01NA,w1kwl1/44.1%.As e ''W LABORATORIES • I ', EPSTEIN, • .3 D08:01/20/1953 Address:9 NEW YORK, P: (212) t ...e Ti —s.t. JEFFREY Age:63 Y Sex:M E 71ST STREET NY 10021 772-9416 RISCH, HARR

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre